A Women’s Health Initiative trial showed that BMI associated with a higher risk of ER+ and PR+ breast cancer, with hazard ratios (HR) increasing with each BMI level (HR, 1.86; 95%CI, 1.60–2.17 for BMI ≥ 35.0) [11]. This evidence concerns the gene PGR and breast carcinoma.